Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines

BACKGROUND: Canadian and international data suggest the risk of myocarditis and/or pericarditis is elevated during the week after mRNA COVID-19 vaccination, particularly in younger age groups, in males, and after second doses. OBJECTIVES: This article examines whether there is a product-specific dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Abraham, Natalia, Spruin, Sarah, Rossi, Tanya, Fireman, Bruce, Zafack, Joseline, Blaser, Christine, Shaw, Amanda, Hutchings, Kimberley, Ogunnaike-Cooke, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130641/
https://www.ncbi.nlm.nih.gov/pubmed/35750537
http://dx.doi.org/10.1016/j.vaccine.2022.05.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130641/
https://www.ncbi.nlm.nih.gov/pubmed/35750537
http://dx.doi.org/10.1016/j.vaccine.2022.05.048

Ejemplares similares